Rotavirus (RV) is a double-stranded ribonucleic acid virus, which belongs to the reovirus family. It is the single leading cause of diarrhea in infants and young children, and almost every child in the world around the age of five has been infected with rotavirus at least once.
This report contains market size and forecasts of Rotavirus Infection Therapeutics in Global, including the following market information:
Global Rotavirus Infection Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rotavirus Infection Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rotavirus Infection Therapeutics include GlaxoSmithKline, Bharat Biotech, Curevac, Ology Bioservices and BioKangtai, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rotavirus Infection Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rotavirus Infection Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rotavirus Infection Therapeutics Market Segment Percentages, by Type, 2021 (%)
Oral Drug
Injiectable Drug
Global Rotavirus Infection Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rotavirus Infection Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Rotavirus Infection Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rotavirus Infection Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rotavirus Infection Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rotavirus Infection Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Bharat Biotech
Curevac
Ology Bioservices
BioKangtai